Radek Jorda

17PUBLICATIONS
51CO-AUTHORS
Characterisation of biological macromoleculesHaematological tumoursGlycoconjugatesCheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 24, 2025
Isoxazole-Based Compounds Targeting the Taxane-Binding Site of Tubulin.

Miroslav Peřina, Márton A Kiss, Jakub Bělíček

|May 25, 2024
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs.

Thalia Delgado, Denisa Veselá, Hana Dostálová

|Dec 14, 2023
Synthesis and Antiproliferative Evaluation of d-Glucuronamide-Based Nucleosides and (Triazolyl)methyl Amide-Linked Pseudodisaccharide Nucleosides.

Tânia Moreira, Domingos M Manuel, Joana Rosa

|Aug 03, 2023
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping.

Petra Břehová, Eva Řezníčková, Kryštof Škach

|Mar 28, 2023
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022).

Markéta Kovalová, Joseph Peter Baraka, Václav Mik

|Dec 23, 2022
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors.

Monika Tomanová, Karolína Kozlanská, Radek Jorda

Pageof 3

Frequent Collaborators

13 joint publications

Vladimír Kryštof

5 joint publications

Veronika Vojáčková

3 joint publications

Eva Řezníčková

3 joint publications

Miroslav Peřina